Palvella Therapeutics CSO Jeffrey S. Martini Sells $2.08M of Stock
Jeffrey S. Martini, CSO, sold 12,500 shares of Palvella Therapeutics, Inc. at $163.34 to $172.12 a share (average $166.65) in 13 transactions, worth $2.08M in total between Nov 10, 2026 and Nov 11, 2026. Shares held after the trade: 0 (-100.0%).
Palvella Therapeutics COO Kathleen Goin Sells $537K of Stock
Kathleen Goin, COO, sold 4,313 shares of Palvella Therapeutics, Inc. at $123.62 to $126.19 a share (average $124.58) in 3 transactions, worth $537K in total on Oct 21, 2026. Shares held after the trade: 0 (-100.0%).
Palvella Therapeutics Insider George M. Jenkins Sells $3.58M of Stock
George M. Jenkins sold 27,500 shares of Palvella Therapeutics, Inc. at $121.14 to $136.44 a share (average $130.16) in 17 transactions, worth $3.58M in total between Oct 12, 2026 and Oct 14, 2026. Shares held after the trade: 132,616 (-0.4%).
Palvella Therapeutics COO Kathleen Goin Sells $655K of Stock
Kathleen Goin, COO, sold 4,302 shares of Palvella Therapeutics, Inc. at $151.16 to $153.24 a share (average $152.24) in 3 transactions, worth $655K in total on Sep 16, 2026. Shares held after the trade: 0 (-100.0%).